DNA甲基化调解了转移性子宫内膜透明细胞癌中免疫抑制性瘤微环境
Huiqing Jia1, Yang Chen1, Guofeng Ma2
1Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
EBioMedicine
|October 1, 2025
概括
子宫内膜透明细胞癌 (ECCC) 转移是由表观遗传-免疫轴驱动的,其中DNA甲基化使免疫基因沉默. 这项研究确定了LCK作为治疗点,并制定了ECCC的风险评分.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 子宫内膜透明细胞癌 (ECCC) 是一种罕见的,侵略性的,对转移机制了解甚少.
- 在ECCC中转移与免疫抑制性瘤微环境 (TME) 有关.
研究的目的:
- 区分转移性与非转移性ECCC的分子特征.
- 为了研究DNA甲基化在ECCC转移中的作用.
- 确定表观遗传生物标志物和治疗点.
主要方法:
- 在测序队列 (n=35) 中进行整体基因组甲基化和转录组分析.
- 在单独的队列 (n=16) 中进行组织微阵列验证.
- 使用TME和表观遗传特征开发转移风险评分模型.
主要成果:
- 转移性ECCC表现出更具免疫抑制性的TME,瘤透淋巴细胞 (TIL) 较少.
- 转移性瘤中的差异性DNA超甲基化在表观遗传上调节免疫反应,包括ETS1活性.
- 对T细胞受体 (TCR) 信号基因 (LCK,CD3E,ZAP70) 的表观遗传沉默会损害T细胞的激活.
- 包括TIL密度和LCK甲基化在内的转移风险得分实现了高预测性表现 (AUC=0.859).
结论:
- "表观遗传-免疫轴"是ECCC转移的一个关键驱动因素.
- DNA甲基化使免疫基因沉默,促进免疫抑制的TME并促进转移.
- LCK是一个潜在的治疗目标,风险评分有助于精确治疗ECCC.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Genomic Imprinting and Inheritance
36.8K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.8K


